G

CytoMed Therapeutics Limited
D

GDTC

2.30000
USD
0.16
(7.48%)
مغلق
حجم التداول
36
الربح لكل سهم
0
العائد الربحي
-
P/E
-13
حجم السوق
26,542,000
أصول ذات صلة
AAPL
AAPL
0.670
(0.34%)
196.260 USD
AMZN
AMZN
-2.280
(-1.06%)
212.530 USD
BABA
BABA
-1.585
(-1.38%)
113.490 USD
GOOGL
GOOGL
-2.630
(-1.50%)
173.290 USD
MSFT
MSFT
2.19
(0.46%)
480.23 USD
NFLX
NFLX
1.07
(0.09%)
1,221.75 USD
NVDA
NVDA
1.430
(0.99%)
145.470 USD
TSLA
TSLA
5.92
(1.87%)
322.14 USD
V
V
-17.52
(-4.90%)
340.32 USD
المزيد
المقالات

العنوان: CytoMed Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.